Which of the following is effective in management of patients of hea failure with preserved ejection fraction?
HFpEF (hea failure with preserved ejection fraction)- A.R.N.I (ARB & Nephrilysin inhibitor) HFrEF (hea failure with reduced ejection fraction)- ACE inhibitor+ Beta Blocker Phosphodiesterase inhibitor: RELAX trial- no improvement in functional capacity, quality of life (QOL), or other clinical and surrogate parameters in patients with HFpEF. Isosorbide mononitrate: (NEAT-HFpEF) trial- no improvement in QOL or submaximal exercise capacity in patients with HFpEF Digoxin Digitalis Investigation Group (DIG) found no role for digoxin in the treatment of HFpEF.
Digoxin
ARB with neprilysin inhibitor
Isosorbide mononitrate
Phosphodiesterase inhibitor
Hea failure